Trials / Conditions / Peripheral Blood Stem Cell Transplantation

Peripheral Blood Stem Cell Transplantation

14 registered clinical trials studyying Peripheral Blood Stem Cell Transplantation — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Eltrombopag for Peripheral Blood Stem Cell Harvest NCT05961410	National Taiwan University Hospital	Phase 2
Recruiting	The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycopheno NCT05436418	National Cancer Institute (NCI)	Phase 1 / Phase 2
Active Not Recruiting	GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG NCT05153226	DKMS gemeinnützige GmbH	Phase 3
Unknown	Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen NCT05088226	Chinese PLA General Hospital	Phase 2
Unknown	Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma NCT05075681	Chinese PLA General Hospital	Phase 1 / Phase 2
Unknown	Ruxolitinib and Decitabine for High Risk Hematological Malignancies NCT04582604	Chinese PLA General Hospital	Phase 1 / Phase 2
Completed	KRN125 for Mobilization of Hematopoietic Stem Cells NCT03993639	Kyowa Kirin Co., Ltd.	Phase 2
Unknown	Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignanc NCT03771222	Chinese PLA General Hospital	Phase 2
Unknown	Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD NCT02848105	Shanghai Jiao Tong University School of Medicine	Phase 2
Completed	Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT NCT02398708	University of Florida	—
Terminated	Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant NCT02326675	University of Florida	N/A
Completed	A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Al NCT00670423	Jennifer E. Schwartz	Phase 1
Terminated	Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells NCT02512679	Children's Hospital Los Angeles	Phase 2
Completed	Incidence and Factors Associated With the Development and Severity of Oral Mucositis NCT00575809	The University of Texas Health Science Center at San Antonio	—